We are live on
!
Find out more
ELC
Edgar Lomax Company Portfolio holdings
AUM
$1.4B
1-Year Est. Return
20.67%
This Fund
S&P 500
This Quarter
Est. Return
+16.58%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.47B
AUM Growth
+$174M
(+13%)
Cap. Flow
-$24.3M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
42.92%
Holding
64
New
2
Increased
–
Reduced
53
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$3.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.91M |
| 2 |
Exelon
EXC
|
+$1.31M |
| 3 |
Allstate
ALL
|
+$1.26M |
| 4 |
Cisco
CSCO
|
+$1.21M |
| 5 |
MetLife
MET
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.23% |
| 2 | Industrials | 16.27% |
| 3 | Healthcare | 10.94% |
| 4 | Communication Services | 9.86% |
| 5 | Technology | 9.46% |
Similar funds
FCP
TWM
AI
IAS
EA
QC
SCM
SP
Edgar Lomax Company's Q4 2020 Portfolio in Review
As of Q4 2020, Edgar Lomax Company held 64 positions worth $1.47B, up 13% from $1.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Trading was light in Q4 2020: portfolio turnover was 3.1%. Edgar Lomax Company opened 2 new positions and made no exits, leaving the 64-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.
- Edgar Lomax Company's largest Q4 2020 buy was Viatris: 225,217 shares worth $4.22M.
- Edgar Lomax Company's biggest Q4 2020 reduction was Pfizer, cutting an estimated $4.91M.
- Edgar Lomax Company's ten largest holdings make up 43% of its $1.47B portfolio in Q4 2020.
- Edgar Lomax Company opened 2 new positions and closed 0 in Q4 2020.
- Edgar Lomax Company's portfolio value rose 13% quarter-over-quarter to $1.47B.
Based on Edgar Lomax Company's 13F filing for Q4 2020, filed 11 Feb 2021.